News Digging > Popular > Health News Roundup: U.S. FDA declines to approve Cytokinetics' heart drug; FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern and more
Health News Roundup: U.S. FDA declines to approve Cytokinetics' heart drug; FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern and more
Health News Roundup: U.S. FDA declines to approve Cytokinetics' heart drug; FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern and more,Wall Street analysts said Dunn's departure could impact the regulator's stance on neurological drug decisions in the near term, sending down shares of Reata Pharmaceuticals Inc 30% on Monday when media reports on the exit surfaced. Pfizer gets FDA panel's backing in RSV vaccine race A panel of outside advisers to the U.S. health regulator on Tuesday recommended Pfizer Inc's respiratory syncytial virus (RSV) vaccine, bringing it closer to becoming one of the first approved RSV shots for older adults in the United States.

Health News Roundup: U.S. FDA declines to approve Cytokinetics' heart drug; FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern and more

Wall Street analysts said Dunn's departure could impact the regulator's stance on neurological drug decisions in the near term, sending down shares of Reata Pharmaceuticals Inc 30% on Monday when media reports on the exit surfaced. Pfizer gets FDA panel's backing in RSV vaccine race A panel of outside advisers to the U.S. health regulator on Tuesday recommended Pfizer Inc's respiratory syncytial virus (RSV) vaccine, bringing it closer to becoming one of the first approved RSV shots for older adults in the United States.